Global trends and molecular epidemiology of Azithromycin-resistant Salmonella: A systematic review and meta-analysis

Getachew Mengistu, Mekuanint Geta, Anwar Nuru, Baye Gelaw, Feleke Moges · 2026

Read Global trends and molecular epidemiology of Azithromycin-resistant Salmonella: A systematic review and meta-analysis by Getachew Mengistu, Mekuanint Geta, Anwar Nuru, Baye Gelaw, Feleke Moges (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13475687.txt.

Description

Mengistu and colleagues pool global evidence on azithromycin resistance in Salmonella, the foodborne bacterium behind typhoid-like fevers and gut infections, in a 2026 systematic review and meta-analysis. Azithromycin is a key antibiotic when other drugs fail. The team combined studies of resistant isolates worldwide and examined how many shrugged off several drugs at once, plus which genes drove it in each region and bacterial subtype.

Across the pooled studies, 9.12 percent of Salmonella samples shrugged off azithromycin, with a confidence interval running from 6.53 to 12.07 percent in the pooled estimate. Among those, 31.10 percent resisted many drugs and 19.30 percent resisted nearly all drugs in the reported shares. The toolkit included efflux pumps, enzymes that alter the drug, and class 1 integrons. Rates ran highest in Southern Asia and Eastern Europe. Mengistu urges tighter tracking and drug discipline across human and animal care.

Catalog record

CREATORGetachew Mengistu, Mekuanint Geta, Anwar Nuru, Baye Gelaw, Feleke Moges
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13475687

Browse the full library · About the Tower of Babel